Morgan Stanley on on argenx SE (ARGX) - 'Catalyst Driven Idea: Efgartigimod ITP Ph3 Results'
Tweet Send to a Friend
Morgan Stanley analyst Matthew Harrison reiterated an Equalweight rating and $278.00 price target on argenx SE (NASDAQ: ARGX).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
